Literature DB >> 29893227

Clinical management of psoriatic arthritis.

Filip Van den Bosch1, Laura Coates2.   

Abstract

Psoriatic arthritis, or the broader term psoriatic disease, refers to an inflammatory disorder that affects multiple organs, including the skin and joints, and that also has related extra-articular manifestations and can have comorbidities. Patients with psoriatic disease have a substantial clinical burden. Early identification leading to timely diagnosis and treatment is crucial to prevent long-term structural damage and disability and the associated socioeconomic consequences. The increase in therapeutic options, such as disease-modifying anti-rheumatic drugs, both biological and targeted synthetic, has revolutionised the treatment of skin and joint disease, and has prompted clinicians to use the full clinical picture of an individual patient to make rational treatment decisions. Current research is also focused on treatment strategies, including treat to target, early remission-induction, and tapering.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29893227     DOI: 10.1016/S0140-6736(18)30949-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  20 in total

Review 1.  Multidisciplinary Management of Psoriatic Arthritis: The Benefits of a Comprehensive Approach.

Authors:  Elisa Visalli; Natascia Crispino; Rosario Foti
Journal:  Adv Ther       Date:  2019-02-25       Impact factor: 3.845

Review 2.  The History of Psoriatic Arthritis (PsA): From Moll and Wright to Pathway-Specific Therapy.

Authors:  Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2018-08-09       Impact factor: 4.592

3.  The evaluation of the static and dynamic balance disorders in patients with psoriatic arthritis.

Authors:  Mehmet Tuncay Duruoz; Hatice Sule Baklacioglu; Canan Sanal Toprak; Kardelen Gencer Atalay; Mehmet Pamir Atagunduz
Journal:  Rheumatol Int       Date:  2018-08-22       Impact factor: 2.631

4.  Nail and enthesis assessment in patients with psoriatic disease by high frequency ultrasonography: findings from a single-centre cross-sectional study.

Authors:  Piero Ruscitti; Maria Esposito; Camilla Gianneramo; Paola Cipriani; Antonio Barile; Maria Concetta Fargnoli; Ilenia Di Cola; Andrea De Berardinis; Andrea Martinese; Gerard Nkamtse Tochap; Alessandro Conforti; Carlo Masciocchi
Journal:  Radiol Med       Date:  2022-10-19       Impact factor: 6.313

Review 5.  [Biologics and further new drugs for rheumatic diseases since 2000].

Authors:  K Krüger
Journal:  Orthopade       Date:  2018-11       Impact factor: 1.087

Review 6.  Tapering and Discontinuation of Biologics in Patients with Psoriatic Arthritis with Low Disease Activity.

Authors:  Weiyu Ye; Laura J Tucker; Laura C Coates
Journal:  Drugs       Date:  2018-11       Impact factor: 9.546

7.  Physician-patient alignment in satisfaction with psoriatic arthritis treatment in Latin America.

Authors:  Enrique Roberto Soriano; Federico Zazzetti; Ivanio Alves Pereira; José Maldonado Cocco; Valderilio Feijó Azevedo; Generoso Guerra; Wilson Bautista-Molano; Julio César Casasola; David Vega Morales; Diana Rocío Gil; Steve Lobosco; Fabio Lawson
Journal:  Clin Rheumatol       Date:  2020-01-28       Impact factor: 2.980

8.  Upregulation of miR-941 in Circulating CD14+ Monocytes Enhances Osteoclast Activation via WNT16 Inhibition in Patients with Psoriatic Arthritis.

Authors:  Shang-Hung Lin; Ji-Chen Ho; Sung-Chou Li; Yu-Wen Cheng; Yi-Chien Yang; Jia-Feng Chen; Chung-Yuan Hsu; Toshiaki Nakano; Feng-Sheng Wang; Ming-Yu Yang; Chih-Hung Lee; Chang-Chun Hsiao
Journal:  Int J Mol Sci       Date:  2020-06-17       Impact factor: 5.923

9.  Comprehensive analyses of long non-coding RNA expression profiles by RNA sequencing and exploration of their potency as biomarkers in psoriatic arthritis patients.

Authors:  Tao Yue; Mei Ji; Huanru Qu; Mengru Guo; Fengmin Bai; Zhanming Zhang; Weifeng Wang; Xuming Gong; Zhenghua Zhang
Journal:  BMC Immunol       Date:  2019-08-07       Impact factor: 3.615

10.  Sustained remission with methotrexate monotherapy after 22-week induction treatment with TNF-alpha inhibitor and methotrexate in early psoriatic arthritis: an open-label extension of a randomized placebo-controlled trial.

Authors:  Henriëtte M Y de Jong; Leonieke J J van Mens; Michael T Nurmohamed; Marc R Kok; Arno W R van Kuijk; Dominique L P Baeten; Marleen G H van de Sande
Journal:  Arthritis Res Ther       Date:  2019-09-14       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.